Multiple Autism-Linked Genes Mediate Synapse Elimination via Proteasomal Degradation of a Synaptic Scaffold PSD-95

被引:246
作者
Tsai, Nien-Pei [1 ]
Wilkerson, Julia R. [1 ]
Guo, Weirui [1 ]
Maksimova, Marina A. [1 ]
DeMartino, George N. [2 ]
Cowan, Christopher W. [3 ,4 ]
Huber, Kimberly M. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA
[4] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA
基金
美国国家卫生研究院;
关键词
FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; MESSENGER-RNA; OL-PROTOCADHERIN; TRANSLATION; MEF2; ENDOCYTOSIS; TRAFFICKING; EXPRESSION; DIVERSITY;
D O I
10.1016/j.cell.2012.11.040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The activity-dependent transcription factor myocyte enhancer factor 2 (MEF2) induces excitatory synapse elimination in mouse neurons, which requires fragile X mental retardation protein (FMRP), an RNA-binding protein implicated in human cognitive dysfunction and autism. We report here that protocadherin 10 (Pcdh10), an autism-spectrum disorders gene, is necessary for this process. MEF2 and FMRP cooperatively regulate the expression of Pcdh10. Upon MEF2 activation, PSD-95 is ubiquitinated by the ubiquitin E3 ligase murine double minute 2 (Mdm2) and then binds to Pcdh10, which links it to the proteasome for degradation. Blockade of the Pcdh10-proteasome interaction inhibits MEF2-induced PSD-95 degradation and synapse elimination. In FMRP-lacking neurons, elevated protein levels of eukaryotic translation elongation factor 1 alpha (EF1 alpha), an Mdm2-interacting protein and FMRP target mRNA, sequester Mdm2 and prevent MEF2-induced PSD-95 ubiquitination and synapse elimination. Together, our findings reveal roles for multiple autism-linked genes in activity-dependent synapse elimination.
引用
收藏
页码:1581 / 1594
页数:14
相关论文
共 41 条
[1]
Advances in autism genetics: on the threshold of a new neurobiology [J].
Abrahams, Brett S. ;
Geschwind, Daniel H. .
NATURE REVIEWS GENETICS, 2008, 9 (05) :341-355
[2]
From mRNP trafficking to spine dysmorphogenesis: The roots of fragile X syndrome [J].
Bagni, C ;
Greenough, WT .
NATURE REVIEWS NEUROSCIENCE, 2005, 6 (05) :376-387
[3]
Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function [J].
Bassell, Gary J. ;
Warren, Stephen T. .
NEURON, 2008, 60 (02) :201-214
[4]
Berry-Kravis E, 2002, DEV MED CHILD NEUROL, V44, P724
[5]
Autophosphorylated CaMKIIα Acts as a Scaffold to Recruit Proteasomes to Dendritic Spines [J].
Bingol, Baris ;
Wang, Chi-Fong ;
Arnott, David ;
Cheng, Dongmei ;
Peng, Junmin ;
Sheng, Morgan .
CELL, 2010, 140 (04) :567-578
[6]
Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression [J].
Colledge, M ;
Snyder, EM ;
Crozier, RA ;
Soderling, JA ;
Jin, YT ;
Langeberg, LK ;
Lu, H ;
Bear, MF ;
Scott, JD .
NEURON, 2003, 40 (03) :595-607
[7]
Proteasomes: Machines for all reasons [J].
DeMartino, George N. ;
Gillette, Thomas G. .
CELL, 2007, 129 (04) :659-662
[8]
Mechanism-based approaches to treating fragile X [J].
Dolen, Gul ;
Carpenter, Randall L. ;
Ocain, Timothy D. ;
Bear, Mark F. .
PHARMACOLOGY & THERAPEUTICS, 2010, 127 (01) :78-93
[9]
Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers [J].
Dolezelova, Pavlina ;
Cetkovska, Katerina ;
Vousden, Karen H. ;
Uldrijan, Stjepan .
CELL CYCLE, 2012, 11 (05) :953-962
[10]
Genome-Wide Analysis of MEF2 Transcriptional Program Reveals Synaptic Target Genes and Neuronal Activity-Dependent Polyadenylation Site Selection [J].
Flavell, Steven W. ;
Kim, Tae-Kyung ;
Gray, Jesse M. ;
Harmin, David A. ;
Hemberg, Martin ;
Hong, Elizabeth J. ;
Markenscoff-Papadimitriou, Eirene ;
Bear, Daniel M. ;
Greenberg, Michael E. .
NEURON, 2008, 60 (06) :1022-1038